Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Nasopharyngeal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01312311
What this trial is testing

Weekly Docetaxel Plus Cisplatin as the First-line Therapy for Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
Samsung Medical Center 51
Large-scale testing (Phase 3)UnknownNCT05576272
What this trial is testing

A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Qilu Pharmaceutical Co., Ltd. 460
Testing effectiveness (Phase 2)Study completedNCT00301028
What this trial is testing

Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 48
Testing effectiveness (Phase 2)UnknownNCT05520814
What this trial is testing

PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial

Who this might be right for
Nasopharyngeal CarcinomaPD-1 InhibitorsChemoradiotherapy
Sichuan Cancer Hospital and Research Institute 50
Early research (Phase 1)WithdrawnNCT00006106
What this trial is testing

ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Lip and Oral Cavity CancerHead and Neck CancerOropharyngeal Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00062348
What this trial is testing

Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases

Who this might be right for
Colorectal CancerHead and Neck CancerMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 27
Testing effectiveness (Phase 2)Study completedNCT03848286
What this trial is testing

KL-A167 Injection in Recurrent or Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaRecurrent or Metastatic
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 153
Testing effectiveness (Phase 2)Active Not RecruitingNCT05807880
What this trial is testing

Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
Sun Yat-sen University 59
Large-scale testing (Phase 3)Not Yet RecruitingNCT06719479
What this trial is testing

A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).

Who this might be right for
NPCHNSCCRecurrence+1 more
SUNHO（China）BioPharmaceutical CO., Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00509665
What this trial is testing

Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Medical University of South Carolina 18
Testing effectiveness (Phase 2)UnknownNCT03213587
What this trial is testing

Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital 51
Not applicableLooking for participantsNCT01365169
What this trial is testing

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Who this might be right for
Malignant Head and Neck NeoplasmMalignant NeoplasmMetastatic Malignant Neoplasm in the Neck+45 more
M.D. Anderson Cancer Center 590
Not applicableLooking for participantsNCT06321939
What this trial is testing

Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal CarcinomaHerpesvirus 4, Human
Hunan Cancer Hospital 50
Testing effectiveness (Phase 2)Temporarily pausedNCT05904080
What this trial is testing

Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer

Who this might be right for
Metastatic Nasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaStage IV Nasopharyngeal Carcinoma AJCC v8
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)UnknownNCT04830267
What this trial is testing

The Efficacy of Camrelizumab Plus Stereotactic Body Radiotherapy in R/M NPC

Who this might be right for
Nasopharyngeal Carcinoma
Chongqing University Cancer Hospital 39
Testing effectiveness (Phase 2)UnknownNCT05417139
What this trial is testing

Sintilimab Combined With Chemotherapy and Radiotherapy in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Multicenter Study

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06331845
What this trial is testing

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Metastatic Nasopharyngeal CarcinomaIntermittent Systematic Chemotherapy
Fujian Cancer Hospital 39
Testing effectiveness (Phase 2)UnknownNCT00363831
What this trial is testing

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
The University of Hong Kong 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04825990
What this trial is testing

Pembrolizumab and Olaparib in Recurrent/Metastatic, Platinum Resistant Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Carcinoma
Gruppo Oncologico del Nord-Ovest 30
Large-scale testing (Phase 3)Looking for participantsNCT07705243
What this trial is testing

Efficacy and Safety of Becotatug Vedotin (MRG003) Combined With Anti-PD1 as Maintenance Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University 86
Next Page